the firm's post-grant practitioners are some of the most experienced in the country.

Johnny  Ma
Kurt M. Berger, Ph.D.
Aristotelis M. Psitos
Matthew H. Everhart, Ph.D.
Ryan W. Smith
Frank J. West
Andrew M. Ollis
Yin Y. Nelson, Ph.D.
Alexander B. Englehart
Michael R. Casey, Ph.D.
Edwin D. Garlepp
Tao  Feng, Ph.D.
Norman F. Oblon
Dale M. Shaw
Craig R. Feinberg
Elissa L. Sanford
Charles L. Gholz
Jeffrey B. McIntyre
Long  Phan, Ph.D.
Philippe J.C. Signore, Ph.D.
Erik M. Stang, Ph.D.
Bogdan A. Zinchenko
Brian B. Darville
Stephen G. Baxter, Ph.D.
Carl E. Schlier
Richard D. Kelly
Soumya  Panda
Robert W. Downs
Marina I. Miller, Ph.D.
Maki  Saitoh
Kasumi  Kanetaka
Kevin M. McKinley
Jianping (James)  Wu
Peifang  Tian, Ph.D.
Akihiro  Yamazaki
Thomas M. Cunningham, Ph.D.
Chika (Teranishi) Iitoyo
Tia D. Fenton
John  Sipos
Eckhard H. Kuesters
J. Derek  Mason, Ph.D., CLP
Christopher I. Donahue
Yorikatsu  Hohokabe, Ph.D.
Robert T. Pous
Nicholas  Rosa, Ph.D.
Stefan Uwe  Koschmieder, Ph.D.
Surinder  Sachar
Steven B. Chang
Derek  Lightner, Ph.D.
Kevin Ross  Davis
Anna Z. Lloyd
Aldo  Martinez
Nanlin  Wang, Ph.D.
Ching-Cheng (Tony)  Chang
Diane  Jones
James R. Love
Colin B. Harris
Kevin L. Hartman, Ph.D.
Christopher  Ricciuti
David M. Longo, Ph.D.
Daniel J. Pereira, Ph.D.
Yanwen  Fei
Arthur I. Neustadt
Grace E. Kim
Sameer  Gokhale
Jay E. Rowe, Jr., Ph.D.
John S. Kern
Eric W. Schweibenz
Robert  Tarcu
Yuanyi (Alex) Zhang
John F. Presper
Vincent K. Shier, Ph.D.
Alec M. Royka
Teddy S. Gron
Yuki  Onoe
Jenchieh (Joseph) Yuan


Artificial Intelligence (AI)
Artificial Intelligence (AI)
Digital Health
Digital Health
Energy & Renewables
Energy & Renewables

Fast Facts

About Our

Law Firm

About Our Law Firm

Headquartered within steps of the USPTO with an affiliate office in Tokyo, Oblon is one of the largest law firms in the United States focused exclusively on intellectual property law.

Get to know our


Get to know our History

Norman Oblon with Stanley Fisher and Marvin Spivak launched what was to become Oblon, McClelland, Maier & Neustadt, LLP, one of the nation's leading full-service intellectual property law firms.

Our Local and

Global Reach

Our Local and Global Reach

Outside the US, we service companies based in Japan, France, Germany, Italy, Saudi Arabia, and farther corners of the world. Our culturally aware attorneys speak many languages, including Japanese, French, German, Mandarin, Korean, Russian, Arabic, Farsi, Chinese.

A few of our


A few of our ACCOLADES

Oblon's professionals provide industry-leading IP legal services to many of the world's most admired innovators and brands.




From the minute you walk through our doors, you'll become a valuable part of a team that fosters a culture of innovation, client service and collegiality.

A few ways to

GET In Touch

A few ways to GET In Touch
US Office

Telephone: 703-413-3000
Learn More +

Tokyo Office

Telephone: +81-3-6212-0550
Learn More +


Patent Forms

Downloadable Patent Forms

The United States Patent and Trademark Office (USPTO) issued final rules implementing the inventor's oath or declaration provisions of the America Invents Act (AIA) on August 14, 2012.

Vincent K. Shier, Ph.D.

Vincent K. Shier, Ph.D.

Partner ∙ US Office
T: (703) 412-6461
Download My vCard
Download Summary PDF
Download Detailed PDF

Vincent (Vince) K. Shier, Ph.D., is a partner in the firm's Chemical Patent Prosecution and Patent Trial and Appeal Board proceedings practice groups.

Dr. Shier holds bachelor’s degrees in Biology and Chemistry. This cross-disciplinary study carried through his graduate studies where he obtained a doctorate degree in Biological Chemistry. Dr. Shier’s research background spans diverse fields, including biochemistry and molecular biology, as well as biophysical, bioanalytical and bioorganic chemistry. Dr. Shier’s technical background uniquely suits him for handling a vast array of technologies.

As a prosecuting attorney, Dr. Shier’s work involves preparing and prosecuting patent applications in diversified technologies within the chemical and biotechnology disciplines. Some of these areas include genetics, molecular biology, therapeutic methods, pharmaceuticals, DNA microarray technology, diagnostics, plants, food products, renewable energies, batteries, plastics, surface materials, minerals and mineral applications, and a diverse array of other chemical products and processes.

An aspect of Dr. Shier’s practice entails client counselling and the development of patent portfolio management strategies for small and emerging companies, as well as large multi-national corporations.

Dr. Shier has also been involved in several litigation matters. As post-grant challenges at the US Patent and Trademark Office (USPTO) have gained popularity, Dr. Shier’s work has also entailed representing clients in contested proceedings at the USPTO both as the patentee and as the patent challenger. This work includes post-grant proceedings available under the America Invents Act, as well as traditional re-examination and reissue practice. In this capacity, he leads the team responsible for post-grant proceedings in the fields of chemistry, biochemistry, biotechnology, biomedicine, genetics, molecular biology and pharmaceuticals.

In addition to frequently providing industry insight to clients, attorneys and the chemical industry on post-grant proceedings conducted concurrently with litigation, Dr. Shier also lectures throughout the world on the evolving standards of obviousness and patent-eligible subject matter, as well as providing counsel on patent prosecution strategies in the United States.

Dr. Shier’s work has consistently been recognized in the legal industry for both his patent prosecution expertise and his work in post-grant proceedings. Dr. Shier is also an Adjunct Professor at the Antonin Scalia Law School at George Mason teaching Patent Law I and Patent Law II.


  • George Washington University Law School (J.D.)
  • Pennsylvania State University (Ph.D.)
    • Biological Chemistry
  • University of Rochester (B.A.)
    • Biological
    • Chemistry


  • Virginia
  • Registered to practice before the U.S. Patent and Trademark Office
  • U.S. District Court for the Eastern District of Virginia
  • Court of Appeals for the Federal Circuit


  • Intellectual Asset Management (IAM) Patent 1000: selected as one of the top eighteen practitioners in the United States for post-grant proceedings and is a “Recommended” patent attorney in the Washington, D.C. Metro Area for his patent prosecution expertise (2014-2020)

Professional Affiliations

  • American Bar Association, Section of Intellectual Property Law, Patent Inter Partes Proceedings Committee (Committee 104); Special Committee on Biotechnology, Chemistry, Medicine, and Pharmacology (Committee 160)
  • Intellectual Property Owners Association (IPO), Patent Office Practice (U.S.) Committee; Patent Office Inter Partes Proceedings Committee
  • American Intellectual Property Law Association (AIPLA)